A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention (Q37226168)
scientific article published on 23 July 2008
Language:
(P31) (Q13442814)
(P304) S18-25
(P407) (Q1860)
(P433) 3 Suppl 1
(P478) 110
(P577) Wednesday, July 23, 2008
(P921) (Q7215)
(Q134808)
(Q160105)
(P1433) (Q5625182)
(P1476) "A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention" (language: en)
(P2093) David Jenkins
(P2860) (Q40227526)
(Q28267023)
(Q58281465)
(Q44113435)
(Q51968734)
(Q51257523)
(Q43998286)
(Q36584354)
(Q43810647)
(Q45552005)
(Q28236008)
(Q34580726)
(Q29618731)
(Q40276124)
(Q36584410)
(Q35587254)
(Q58053669)
(Q28290509)
(Q58322322)
(Q33883532)
(Q36743797)
(Q29616213)
(Q35788182)
(Q33950682)
(Q57089443)
(Q77568726)
(Q77839458)
(Q36578289)
(Q34042389)
(Q72992807)
(Q34568949)
(Q58296516)
(P13046) (Q7318358)
other details
description scientific article published on 23 July 2008

External Links